STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 880 participants.
Also called NCT06901466
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 880 participants
- Registry
-
NCT06901466
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06901466. Randomized; no masking; primary purpose treatment. Start 2025-06-13 (actual); primary completion 2027-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
- Acronym
- STAR-TEER Ⅰ
- Condition
- Mitral Regurgitation
- Intervention (Drug)
- Experimental: Rivaroxaban monotherapy
- Intervention (Drug)
- Active Comparator: Rivaroxaban+Clopidogrel
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
Record details
- Record id
cardio:ct-nct06901466- Content hash
93393dac5025710dbca404124ea5d218ebb22d96d6599e245486e0895961a6e4